Access Bio Inc (KQ:950130) — Market Cap & Net Worth
Market Cap & Net Worth: Access Bio Inc (950130)
Access Bio Inc (KQ:950130) has a market capitalization of $125.38 Million (₩185.01 Billion) as of June 17, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #18425 globally and #844 in its home market, demonstrating a -0.94% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Access Bio Inc's stock price ₩5260.00 by its total outstanding shares 35173800 (35.17 Million). Review Access Bio Inc (950130) financial obligations to assess the company's total debt and financial obligations.
Access Bio Inc Market Cap History: 2015 to 2025
Access Bio Inc's market capitalization history from 2015 to 2025. Data shows change from $172.10 Million to $125.38 Million (-5.76% CAGR).
Access Bio Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Access Bio Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.50x
Access Bio Inc's market cap is 1.50 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $172.10 Million | $35.58 Billion | $1.26 Billion | 0.00x | 0.14x |
| 2016 | $145.88 Million | $27.99 Million | $262.09K | 5.21x | 556.61x |
| 2017 | $109.17 Million | $26.06 Million | -$5.74 Million | 4.19x | N/A |
| 2018 | $102.14 Million | $36.57 Million | -$3.85 Million | 2.79x | N/A |
| 2019 | $93.44 Million | $36.94 Million | -$15.09 Million | 2.53x | N/A |
| 2021 | $381.39 Million | $441.37 Million | $165.75 Million | 0.86x | 2.30x |
| 2022 | $290.81 Million | $800.23 Million | $268.33 Million | 0.36x | 1.08x |
| 2023 | $213.82 Million | $267.08 Million | -$2.43 Million | 0.80x | N/A |
| 2024 | $123.71 Million | $82.45 Million | -$254.83K | 1.50x | N/A |
Competitor Companies of 950130 by Market Capitalization
Companies near Access Bio Inc in the global market cap rankings as of June 17, 2026.
Key companies related to Access Bio Inc by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #127 globally with a market cap of $177.57 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #182 globally with a market cap of $128.10 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #626 globally with a market cap of $44.18 Billion USD.
- LONZA GROUP UNSP.ADR 1/10 (F:LO3A): Ranked #663 globally with a market cap of $41.04 Billion USD ( €35.10 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #127 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.57 Billion | $472.63 |
| #182 | Danaher Corporation | NYSE:DHR | $128.10 Billion | $181.35 |
| #626 | IDEXX Laboratories Inc | NASDAQ:IDXX | $44.18 Billion | $573.00 |
| #663 | LONZA GROUP UNSP.ADR 1/10 | F:LO3A | $41.04 Billion | €54.50 |
Access Bio Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Access Bio Inc's market cap moved from $172.10 Million to $ 125.38 Million, with a yearly change of -5.76%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | ₩125.38 Million | +1.35% |
| 2024 | ₩123.71 Million | -42.14% |
| 2023 | ₩213.82 Million | -26.48% |
| 2022 | ₩290.81 Million | -23.75% |
| 2021 | ₩381.39 Million | +308.16% |
| 2019 | ₩93.44 Million | -8.52% |
| 2018 | ₩102.14 Million | -6.44% |
| 2017 | ₩109.17 Million | -25.16% |
| 2016 | ₩145.88 Million | -15.24% |
| 2015 | ₩172.10 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of Access Bio Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $125.38 Million USD |
| MoneyControl | $125.38 Million USD |
| MarketWatch | $125.38 Million USD |
| marketcap.company | $125.38 Million USD |
| Reuters | $125.38 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Access Bio Inc
Access Bio, Inc. engages in the research, development, and manufacture of in vitro rapid diagnostic tests, biosensors, and molecular diagnostic products worldwide. The company provides Covid-19 detection kits, which are tests for assessing the current or past presence of SARS-CoV-2.; rapid diagnostic tests, suitable for preliminary diagnosis or emergency medical screening in medical facilities wi… Read more